The folate-chitosan-decorated harmaline nanostructured lipid carrier (FCH-NLC), the efficient selective anticancer nano drug delivery system
Zahra Larian,Masoud Homayouni Tabrizi,Ehsan Karimi,Niloufar Khatamian,Ghazal Hosseini Torshizi,Hedieh Pourmohammadi
DOI: https://doi.org/10.1016/j.jddst.2023.104864
IF: 5
2023-09-03
Journal of Drug Delivery Science and Technology
Abstract:Background The limited solubility of the phytochemical bioactive compounds in aqueous solutions decreases their anticancer potentials. Moreover, the not-selective cytotoxicity of anticancer compounds increases several types of clinical side effects. Therefore, we aimed to encapsulate harmaline in a folate-chitosan-coated nanostructured lipid carrier drug delivery system to evaluate its anticancer activity on human MCF-7 breast cancer cells. Methods The Folate-chitosan-decorated harmaline nanostructured lipid carrier (FCH-NLC) were synthesized and characterized by conducting DLS, FTIR, FESEM, and surface Zeta potential analysis. The FCH-NLC cytotoxicity was determined using an MTT assay on MCF-7 cancer cells compared with a normal HFF cell line. The cell death mechanism was investigated by analyzing the cell cycle status, apoptotic gene expression (Caspase 3, 8, 9), and AO/PI stained cells. Result The 153-nm FCH-NLC (PDI = 0.235) significantly decreased the MCF-7 cell survival by inducing apoptotic gene overexpression (Caspase 3, 8, 9). The meaningfully increased reddish orange dead cells and increased SubG1 arrested cells population indicated the apoptotic death in MCF-7 cancer cells. Conclusion The FCH-NLC selectively induced apoptotic death in the human MCF-7 cancer cells. Their selective apoptotic activity can be attributed to folate receptors in the MCF-7 cancer cells compared with normal HFF cells. Therefore, the FCH-NLC can potentially decrease cancer cell survival through a receptor-mediated endocytosis mechanism. However, further studies are required to verify the FCH-NLC apoptotic mechanism. Graphical abstract Download : Download high-res image (230KB) Download : Download full-size image Zoledronic acid (ZA) has been shown to be beneficial against cancer both directly and indirectly. However, because of its fast absorption by bone, its use in extraskeletal malignancies has been limited. Due to its quick blood clearance, ZA is less effective as a cancer treatment. To utilize the numerous therapeutic properties of ZA, novel delivery strategies are necessary. While maintaining its pharmacological properties, nanomedicine is an excellent method of increasing ZA's circulatory half-life and intratumor accumulation. Nanoparticles (NPs) can enhance drug accumulation in neoplastic tissues by utilizing the increased permeability and retention effect (EPR) of fenestrations in tumor arteries. Loading the molecules inside the NP increases the solubility and stability of the drug and inhibits breakdown by serum proteins. Additionally, the release of the drug could be controlled, preventing early leakage. Diseases of the posterior eye segment are often characterized by intraocular inflammation, which causes, in the long term, severe impairment of eye functions and, ultimately, vision loss. Aimed at enhancing the delivery of anti-inflammatory drugs to the posterior eye segment upon intravitreal administration, we developed liposomes with an engineered surface to control their diffusivity in the vitreous and retina association. Hydrogenated soybean phosphatidylcholine (HSPC)/cholesterol liposomes were coated with (agmatinyl) 6 -maltotriosyl-acetamido-N-(octadec-9-en-1-yl)hexanamide (Agm 6 -M-Oleate), a synthetic non-peptidic cell penetration enhancer (CPE), and/or 5% of mPEG 2kDa -DSPE. The zeta potential of liposomes increased, and the mobility in bovine vitreous and colloidal stability decreased with the Agm 6 -M-Oleate coating concentration. Oppositely, mPEG 2kDa -DSPE decreased the zeta potential of liposomes and restored both the diffusivity and the stability in vitreous. Liposomes with 5 mol% Agm 6 -M-Oleate coating were well tolerated by ARPE-19 retina cells either with or without mPEG 2kDa -DSPE, while 10 mol% Agm 6 -M-Oleate showed cytotoxicity. Agm 6 -M-Oleate promoted the association of liposomes to ARPE-19 cells with respect to plain liposomes, while mPEG 2kDa -DSPE slightly reduced the cell interaction. Dexamethasone hemisuccinate (DH) was remotely loaded into liposomes with a loading capacity of ∼10 wt/wt%. Interestingly, mPEG 2kDa -DSPE coating reduced the rate of DH release and enhanced the disposition of Agm 6 -M-Oleate coated liposomes in the ARPE-19 cell cytosol resulting in a mo -Abstract Truncated-
pharmacology & pharmacy